Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
about
Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodentsGrowth factors in corneal wound healing following refractive surgery: A review.Doxycycline-mediated inhibition of choroidal neovascularization.Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.Melissa officinalis extract inhibits laser-induced choroidal neovascularization in a rat model.Minocycline inhibits alkali burn-induced corneal neovascularization in miceCorneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells.Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells.Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization.Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis.Protective effects of matrix metalloproteinase-12 following corneal injury.Corneal neovascularization during experimental fungal keratitis.Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healingCorneal transparency: genesis, maintenance and dysfunctionNovel aspects of corneal angiogenic and lymphangiogenic privilege.Inflammatory corneal neovascularization: etiopathogenesis.Emerging techniques to treat corneal neovascularisationTransplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model.Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization.Recent drug therapies for corneal neovascularization.Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization.The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model.Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization.Effect of Rho-kinase Inhibitor, Y27632, on Porcine Corneal Endothelial Cell Culture, Inflammation and Immune Regulation.Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model.The Boston Ocular Surface Prosthesis as a novel drug delivery system for bevacizumab.The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats.Anti-neovascular effect of chondrocyte-derived extracellular matrix on corneal alkaline burns in rabbits.
P2860
Q28576276-23ACF5BC-44AE-4FA5-AB20-A15C06918549Q31075797-FB39258B-BFE0-4761-BF52-3A530C760173Q33465433-C788B3B2-F2D0-48ED-846F-7ABEBC2A4746Q33639542-D785B916-59F4-4BCD-BD28-4E5490B200E2Q34193277-F69F86A3-70E2-41CF-8707-9ECD8754CC78Q34338680-2EAEC973-5B7D-4E9F-A82C-FF4330FE512CQ34359185-61548CEB-A556-4780-BF75-28124A9CB939Q35662667-F816F5D0-2263-4228-86A2-DF534A6DF02AQ35706345-A84BFD7E-2674-4BA4-84AA-82A8A59D63B5Q35956190-D8229FFE-8C13-4945-9A81-E8399A2FF5A1Q36103375-087D5EA9-6A21-47D6-87D0-5C793553B599Q36475902-0671ED3E-411A-4B16-9825-C8E30C02782AQ36858935-7DC2CDD2-E9FD-4A17-8BBE-06DD35B714EFQ37132508-82A905BF-E6D3-4B93-A086-EFCC0824EA94Q37373833-4DE694DF-6AE0-42FF-BA45-5E6C74196474Q37471968-E4D2A448-7D77-487F-880E-FAA856863D42Q37500924-FA9C1475-657C-4C44-AD59-CCDE1B5307CAQ37681157-9747BEA3-3D14-47DE-B1DA-EB67BBCF1703Q37940578-183D71D0-6B55-44E4-8773-FE7A72192F5BQ37943247-298E876A-C6CC-4D7A-9F59-AA2833860F9DQ38908590-7056297C-69B7-4141-B644-5249AA7D0C65Q39023803-30433737-08C5-4347-9CA7-39B5AE641882Q39295602-10AD63CD-30D8-444B-AE04-81BA62702F94Q39965612-31E81D8A-990D-4F3E-8F4E-433C7FB995DCQ39987928-D21AD605-A942-4EA1-93BB-4737B62D28A7Q40002867-FAAE7C8B-4C35-4CD6-84A6-E62823BC2BB2Q40971686-FA2A9576-0A9E-4161-9155-1EC77B9597A7Q41655331-062D7554-39C8-4D24-88E0-B3AA42C98E89Q41853291-86C6FE19-3EF4-4B47-B7F0-48F24C9FF71AQ45884964-0FCE0326-4E09-4153-BFE4-AF66521B7864Q47815070-30EE0680-8E13-4728-969F-2FB6601063C1Q51537079-68438D63-A746-4015-B1B8-F9BD72697C2FQ52649889-8C65508E-DEE8-4D5F-9507-BA5E4922EE51
P2860
Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Expression of matrix metallopr ...... ed corneal neovascularization.
@ast
Expression of matrix metallopr ...... ed corneal neovascularization.
@en
type
label
Expression of matrix metallopr ...... ed corneal neovascularization.
@ast
Expression of matrix metallopr ...... ed corneal neovascularization.
@en
prefLabel
Expression of matrix metallopr ...... ed corneal neovascularization.
@ast
Expression of matrix metallopr ...... ed corneal neovascularization.
@en
P2093
P921
P356
P1476
Expression of matrix metallopr ...... ed corneal neovascularization.
@en
P2093
P304
P356
10.1006/EXER.1999.0790
P577
2000-04-01T00:00:00Z